Sort
15,273 grants matching “antimicrobial resistance”
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2020 · AI
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2019 · AI
NIH Director's Pioneer Award
$847,291Evgeny Nudler · New York University School Of Medicine · DP1 · FY2008 · OD
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid
$846,903Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2011 · AI
Role of clonal expansion in HIV-1 persistence
$846,629Ya-Chi Ho · Yale University · R01 · FY2025 · AI
Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes
$846,347Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$846,275Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · ZIA · FY2009 · DC
Host-pathogen interactions during hospital adaptation of MRSA
$845,624Bo Shopsin · New York University School Of Medicine · R01 · FY2019 · AI
NIH Director's Pioneer Award
$845,000Evgeny Nudler · New York University School Of Medicine · DP1 · FY2006 · OD
NIH Director's Pioneer Award
$845,000Evgeny Nudler · New York University School Of Medicine · DP1 · FY2007 · OD
Cellular and Developmental Biology of Coxiella burnetii
$844,445Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis
$842,854William Barrow · Oklahoma State University Stillwater · R01 · FY2012 · AI
Hybrid Antibiotics for Persistent Infections
$842,568Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2024 · AI
Development of a novel agent to treat antimicrobial resistant Neisseria gonorrhoeae
$842,442Terry Roemer · Prokaryotics, Inc. · R44 · FY2020 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid
$841,972Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2012 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$841,703Nitin S Baliga · Institute For Systems Biology · R01 · FY2025 · AI
Identifying novel anti-infectives by high through-put screening in whole animals
$841,655Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2009 · AI
Microbial biomarkers of intestinal MDR colonization after solid organ transplantation
$841,520Anne-Catrin Uhlemann · Columbia University Health Sciences · R01 · FY2025 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$840,721Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2020 · AI
Targeting the Urgent Need for New Antibiotics against Gram-negative âSuperbugsâ
$840,469Jian Li · Monash University · R01 · FY2021 · AI
Targeting the Urgent Need for New Antibiotics against Gram-negative âSuperbugsâ
$840,469Jian Li · Monash University · R01 · FY2020 · AI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
$840,040Yuanpu Peter Di · Florida International University · R01 · FY2025 · AI
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$839,372John R Kirby · Medical College Of Wisconsin · R01 · FY2017 · AI
Preclinical modeling to study Tuberculous Meningitis
$838,739Sanjay Jain · Johns Hopkins University · R56 · FY2019 · AI
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$838,537Jian Li · Monash University · R01 · FY2015 · AI